Hrt Financial LP Black Diamond Therapeutics, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.67 - $5.74 $334,000 - $718,039	125,094 New	125,094 $634,000
Q2 2022 Aug 12, 2022	BUY	$1.5 - $3.63 $15,447 - $37,381	10,298 New	10,298 $25,000
Q4 2021 Feb 14, 2022	SELL	$5.18 - $8.48 $370,349 - $606,286	-71,496 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $156,400 - $229,608	18,487 Added 34.88%	71,496 $604,000
Q2 2021 Aug 16, 2021	BUY	$12.19 - $28.17 $646,179 - $1.49 Million	53,009 New	53,009 $646,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.